Mel Halkyard, VP of Global Digital Transformation & Marketing for U.S. Pet Health Media and Customer Marketing presents. Dylan Hollenberg (Sr. Director of Global Commercial Analysis) , Rich White (Sr. Dir. Technical Services), Lee Cahalan (Sr. Dir. Digital Marketing) and Kelsey Lubin (Research & Dev.) also spoke.

Summary by Rex Rumsey, MBA Candidate Class of ’25

This past Wednesday, Elanco, a global leader in animal health, visited the Kelley School of Business at Indiana University to share insights about their business, industry, and exciting career opportunities. With over 70 years of expertise and roots stemming from its founding under Eli Lilly, Elanco continues to be at the forefront of animal health innovation. Their presentation not only underscored their industry leadership but also offered a glimpse into the vibrant work culture that drives their success.

A Look Inside Elanco:

Elanco operates within a booming global market, valued at $15 billion for pet health and $23 billion for farm animals. Their commitment to animal well-being is evidenced by a portfolio that includes several blockbuster drugs, each generating over $100 million in revenue. These contributions fuel growth across sectors and enhance the quality of care for pets and livestock alike.

The company has leveraged its historical connection with Eli Lilly to remain a leader in research and innovation, particularly within pet drug development, with solutions that can address viruses like Parvo. Elanco’s efforts to deliver sustainable solutions have also been demonstrated by new products like Bovaer. This new, sustainable product serves both the environment and the agricultural industry to help reduce methane, a greenhouse gas, from dairy and beef cattle.

Career Opportunities: Marketing, Data Analytics, Research, and Manufacturing:

During the visit, representatives from Elanco delved into the various roles that drive their business operations. For example, Dylan Hollenberg shared about business intelligence, Rich White spoke about manufacturing, Lee Cahalan spoke about omnichannel engagement, Kelsey Lubin presented about technical development, and Mel Halkyard, a VP at Elanco, shared about the strategic direction of the company.  From research scientists spearheading breakthroughs in animal healthcare to marketing professionals tasked with communicating the benefits of new medications, there was someone that IU biologists, engineers, MSHM, and business students could connect with and learn from.

Building a Culture Where Collaboration Meets Passion:

One of the key takeaways was what makes Elanco unique: its work culture and the industry they operate in. The team described an energizing, open, and close-knit environment that fosters collaboration and innovation. It’s not just about business—at Elanco, employees can bring their pets to work, creating an atmosphere that’s both fun and driven by the passion for improving animal lives. Since their products serve animals and touch many different stakeholders, work at Elanco is described as fun, dynamic, and creative.

B2B, B2C, and B2HC Customers:

Elanco’s broad customer base includes animals, pet owners, B2B businesses, and veterinarians, all of which require strategic and intentional product offerings. Their commitment to providing high-quality solutions ensures that veterinarians and farmers have access to the best care options for both pets and livestock.

The Kelley School of Business is particularly well-suited to prepare students to satisfy this broad customer base, since the Kelley School of Business not only has a Life Science Academy, but also offers consumer marketing and business to business marketing academies to prepare students for these types of healthcare roles. This broad customer approach allows Elanco to remain agile and responsive to the diverse needs of their partners and clients, from small clinics to large-scale agricultural businesses — the types of customers many Indiana students are familiar with.

A Glimpse into the Future:

Elanco’s visit to the Kelley School of Business painted an exciting picture of the future of animal health. Their work in research, innovation, and sustainable solutions continues to push the industry forward. The company’s blend of scientific rigor, customer focus, and collaborative culture makes them a global leader in their industry.

For Kelley students, the event offered invaluable insight into the multitude of career opportunities available at a company like Elanco—whether it’s in research, marketing, data analytics, or manufacturing. The company’s commitment to innovation and a positive work environment makes it an ideal place for those who are passionate about making a difference in the world of animal health. For IU students eager to launch impactful careers, Elanco exemplifies how to innovate with purpose, blending passion, mission, and expertise together to drive change in communities across the globe.

Thanks to the Elanco team for visiting and sharing with Kelley Life Sciences students!

  Rex Rumsey

Rex Rumsey, MBA Candidate Class of ‘25

What company did you intern with this summer?

This summer I interned at Medtronic. I was placed with the Cardiac Pacing Team in Minneapolis, MN.

What was your project this summer?

I worked with the Strategy team to determine how to best leverage Medtronic’s pacing portfolio across different customer segments. To do this, I spent the first 4 weeks analyzing US sales data to understand how device utilization differed across physician types, hospital settings, and geographies. Once completed, I interviewed customers to contextualize the data, learn about different customer segments, and identify barriers and new opportunities. Using these insights, I created a targeting strategy that could generate millions in incremental income and develop an immature market, all while accounting for risk, efficiency, and impact. To generate the NPV model, I used a Monte Carlo simulation to demonstrate why driving adoption from a particular customer was worthwhile and why the strategy is likely to work.

How did your manager facilitate growth over the course of the summer?

Ellen’s experience managing projects, generating stakeholder support, and anticipating business needs made a material difference on the project. Ellen went above and beyond to ensure that I had the opportunity to network within the company, observe surgeries, conduct interviews with physicians, test products, and understand the strategic narrative of the team, which accelerated learnings and helped me clearly communicate my insights to the strategy team, the commercial marketing team, and the R&D team.

Did anything about the internship surprise you?

When I was a Physical Therapist, I knew I was passionate about driving innovation in the healthcare industry, but it was an altogether different experience to work towards that end alongside brilliant colleagues that are eminent engineers, lawyers, physicians, and business professionals. I was surprised at how energizing these cross-functional conversations were and how collaborative decision-making can make 1+1=3, as new solutions are synthesized when the right people come together.

How did Kelley facilitate your success?

Kelley’s focus on business analytics and real client engagements proved to be essential. For example, during the Core, Kelley has multiple Quant courses that teach students how to interrogate data, make decisions using prioritization tools, and account for uncertainty (all of which were important for my project). In addition to this, the Business Marketing Academy and the Life Science Academy provided consulting-like projects during the year, which allowed students to conduct market research, create financial models, and present strategies to actual companies prior to their summer internships.

Rex received an internship offer from Medtronic.  Congruatulations and best wishes to Rex as he finishes his final year at Kelley!

Each quarter Rebecca Slotegraaf, Associate Dean for Research at Kelley, publishes a faculty research bulletin to share the important work of faculty across department are conducting in various sectors of business. The latest issue showcased innovative research in the life sciences field.

One faculty member highlighted is Lucy Yan who is a Life Sciences Research Faculty Fellow through the Kelley Center for the Business of Life Sciences. After a friend faced a health crisis, Lucy Yan, the John & Esther Reese Professor and a professor of operations and decision technologies, became interested in understanding how social media is used by patients seeking help and support. In this video, Yan discusses how social media has changed the healthcare industry and how her research frames our understanding its increasing role.

Check out this interview with Professor Yan as she discusses her research.

*The Center for the Business of Life Sciences drives the Kelley School of Business’s life sciences agenda and connects internal and external audiences interested in the school’s life sciences outreach, academic programs, and research. The center reinforces the value of life sciences as a driver for growth and brings together students, faculty, life science companies, and other corporate partners. It is just one part of Indiana University’s commitment to the life sciences. View the list of Kelley Life Sciences Faculty Fellows and their research areas here.

On Thursday, May 16 over twenty faculty and staff from IU and the Bloomington Economic Development Corporation toured the Boston Scientific manufacturing site in Spencer and Cook Medical World Headquarters in Bloomington. The event was organized by the Center for the Business of Life Sciences at the Kelley School.

The delegation was comprised of Sreeni Kamma, associate dean; RJ Niewoehner, operations & decisions technologies faculty; Mel Beldock, undergraduate career services; Jeremy Harmon, graduate career services; Kim Goad and Ron Thomas of Kelley Executive Education Partners and Kelli Conder and George Telthorst of the Kelley School of Business in addition to associate dean Travis Brown and Emma Raver of the Luddy School of Informatics and Computer Engineering. The O’Neill School of Public and Environmental Affairs was represented by environmental governance faculty Kenneth Richards and Steven Bonney of career services.  The College of Arts & Sciences biotech faculty members Nancy Magill, Dave Bollivar, Dan Held and Dan Watts gave updates on the major established a few years ago and how it relates to the medical device industry.  The College’s Walter Center for Career Achievement external relations team members Andrea White and Elizabeth Bolyard attended as well. The Bloomington Economic Development Corporation President Jennifer Pearl & Clark Greiner, Business Development Director, and Owen County Chamber of Commerce CEO Marce King rounded out the discussion from a local workforce perspective.

IU representatives at Boston Scientific’s manufacturing site in Spencer, IN.

At both sites IU and BEDC representatives were able to take tours of the production facility to see how products are manufactured and view finished goods. Amazing the level of detail, logistics, sanitation, tracking and quality control that goes into every device to ensure safety and efficacy to help improve the lives of patients around the world! It’s impressive to think that product just miles from Indiana University from both of these facilities is shipped out to markets all over the world!

IU representatives at Cook Medical World Headquarters in Bloomington, IN.

Following the tours teams in roles that ranged from HR, finance, operations and product management took the time to meet with the group to talk about their workforce needs, skills they are looking for as well as intern and full time opportunities to grow their workforce pipeline. Each school represented talked about programs at the undergraduate, graduate and executive education levels and how those skills align with needs of these organizations. During this discussion there was a lot of exciting new possibilities of future collaborations and relationships to be initiated! As Brian Covert, global communications manager at Cook, said “our team commented later how much engagement and energy was in the room — on both sides”. Moriah Sowders, senior manager for communications & external relations at Boston Scientific shared she’s” hopeful that it’s just the beginning to more meaningful collaboration between Boston Scientific and IU”.

These opportunities will benefit students during and after their academic years into their careers in the life sciences which is a goal for all.  A very special thank you to Boston Scientific and Cook Medical for hosting!

Panel at Boston Scientific talking about roles, workforce needs and opportunities.

During the second half of the spring semester, two teams of three Kelley MBA students each completed projects working with the Chemical Genomics Core Facility (CGCF) through the Indiana Clinical and Translational Sciences Institute. One team was tasked with increasing market access and service awareness while the other looked at benchmarking and project management regarding equipment usage, maintenance, and new equipment purchasing.

The CGCF is a part of the IU School of Medicine and has machines to perform small molecule informatics, design, and synthesis to facilitate high-throughput screening. They work with both academics and small life science companies for small and large molecule analysis. At the start of the project the team traveled to Indianapolis to meet with the client, tour the facilities, and better understand the challenges they are facing.

Marketing Team

Summary by DJ Tuttle, MBA Class of ’24

Team members included DJ Tuttle, Rex Rumsey, and Sandeep Singh Deora. In looking into the CGCF website analytics we saw a decline in monthly visits over the last 2 years with no organized marketing strategy to raise awareness among academics or industry. In addition, there is no distinct marketing person, and all marketing efforts must be done by the scientists. In talking with the Core members, they noted that they had done some initiatives previously, but there was nothing consistent or recent.

We used the marketing funnel as a tool to explain the journey that customers make prior to purchasing. It served to illustrate the importance of the first levels of the funnel. Our recommendations centered around raising awareness, building interest, and increasing consideration. Given the limited marketing resources, we rated our top recommendations based on ease of implementation, hours investment required and the final impact it would have.

Throughout the course of the project, we focused heavily on the use of their website as a low difficulty for implementation and low time investment way to have a high impact. Working with a Digital Marketing representative from IU school of Medicine and CGCF we looked at ways to improve and update the current website interface. We wanted clear, concise information that allowed for users to engage and follow up with the CGCF Team.

Although the nature of the class does not allow for continued formal follow-up to see if our recommendations were successful, in the final discussion we reviewed the use of the website analytics dashboard in tracking visitors. We also stressed the importance of tracking engagement after different initiatives to measure success and guide repeating an initiative. Two of the three team members still have another year of school so can informally check-in with CGCF to make sure their valuable work is properly marketed. We enjoyed working with the team and are excited to see how they bring to life our recommendations.

Benchmarking Team

Summary by Carolina Herrera, MBA Class of ‘25

Team members included Carolina Herrera, Sarah Mrabet, and Youssef Ezzaoui Rahali. As our main objective for the benchmarking project, we wanted to understand the overall operational status among different teams, best practices, and summarize our findings so the CGCF could conduct interviews themselves to other core facilities. We interviewed six different core facilities at IU, Purdue, and Stanford. Our research focused on six operational aspects: equipment, hiring and training process, quality and audits, ROI and pricing, scheduling, and marketing and communications.

In looking into equipment management, we found that they face rising costs and limited opportunities for negotiation. For disposals, cores typically handle them through trade-ins and university surplus services. For hiring new members, cores face a lengthy process (six to seven months), combined with a tight budget. Even though it was an idea at the beginning of the project, sharing a resource between cores doesn’t seem like a viable option, due to specialized work requirements and time commitment needed (as much as a full time job). For quality and audits, most of the facilities send quality surveys to customers, and communicate their performance assessment through iLab messaging.

On the other side, there’s a lack of formal ROI analysis. Labs measure mostly equipment utilization and variance of usage hours. Pricing strategies are usually different across the cores, with some of them utilizing cost-based pricing, and others offering discounts to already trained students that want to use the lab services. Finally, when looking at Marketing, cores don’t have a specific budget for it, or a dedicated person to focus only in promoting their services.

Our recommendations centered in internal and external next steps to follow. Internally, we suggested creating a shortlist of core labs with high collaboration potential, and map user journey to understand improvement opportunities. Externally, we suggested discussing bundle services with complementary labs, and request marketing support from the different machines manufacturers.

“Working with Kelley MBA students was an eye-opening experience for our Core members. Two teams of MBA students explored various marketing avenues, performed surveys, and created benchmarks for future performance indicators. The CTSI-Kelley core management project showed its value at this first step, and we will be happy to follow up with its implementation. Great work and thanks to the Kelley teams!!”

-Jingwei Meng, Director of High Throughput Screening, Chemical Genomics Core, Indiana Clinical and Translational Sciences Institute & Assistant Research Professor of Biochemistry & Molecular Biology, IU School of Medicine.

*Founded in 2008, the Indiana Clinical and Translational Sciences Institute (CTSI) is a statewide research partnership among Indiana University, Purdue University, the University of Notre Dame, and Regenstrief Institute, along with a number of life sciences organizations, governmental entities and community groups. The Indiana CTSI also engages with the public at every level of research—from basic science to patient care. It has been continuously funded by multimillion-dollar grants from the National Institutes of Health since the Indiana CTSI’s founding in 2008 and is housed at the Indiana University School of Medicine.

Mark Brincat (Zimmer Biomet)

On Friday, April 19^th the Kelley Center for the Business of Life Sciences held the Indiana Life Sciences Collaboration Conference; Tech: Don’t Be Afraid of Healthcare! hosted by the Indiana Biosciences Research Institute (IBRI) in Indianapolis. Series sponsors included Commissioning Agents, Inc., Eli Lilly and Company, LabCorp Drug Development and Reckitt along with primary sponsors Fort Wayne Metals, Indiana Biosciences Research Institute, Paragon Medical, Taft Stettinius & Hollister LLP and Zimmer Biomet.  Supporting sponsors were BioCrossroads, The Bloomington Economic Development Corporation, Blueprint Marketing Group and Miles Printing.

Life Sciences professionals in the industry provided their latest thinking on the use of AI and big data, its business implications, and contributions by Indiana firms.

Mark Brincat, Senior Director for AI, at Zimmer Biomet kicked off the event with the keynote “Building a sustainable data centric strategy in healthcare”. Brincat has a computer science background with several years of life sciences and MedTech experience including Pfizer, leading many of the clinical and digital therapeutic innovations.  He also worked in the start-up space building products for the top 20 pharmaceutical companies. Prior to Zimmer Biomet, Brincat led the development of McLaren’s Applied Technologies Healthcare business, building an innovative AI platform to support customers across fitness, wellness, and healthcare market. One of Brincat’s primary drivers is in delivering scalable and sustainable digital healthcare solutions to market and working to drive industry ecosystems.

During his keynote, Mr. Brincat commented that many beliefs from the last 100 years still dominate and are being applied. He believes data is crucial to track and observe and inform decisions. He feels if companies are not on board currently with AI, they will be left behind over the next 2-5 years. He previewed emerging AI, how to navigate implementation, differences in life sciences sectors, generative AI, how to build sustainable products, cost, legislation & regulation, and an overview of how the industry is currently managing AI and the business implications.

View Presentation: Brincat

Travis Johnson (Indiana Biosciences Research Institute), Nicek Scheau (Eli Lilly) and Krista Toler (Zimmer Biomet)

A panel focused on research followed focused on AI’s impact on research.  Moderated by Lisa Soard of IBRI, the panel included Travis Johnson, Agnes Beaudry investigator in Myeloma Research at the IU School of Medicine & director of bioinformatics at the IBRI; Nick Scheu, business information security officer for Eli Lilly; and Krista Toler, associate director of research and development at Zimmer Biomet.

Travis Johnson spoke of how he uses AI to synthesize large amounts of data to identify diseased cellular subtypes, markers, drug response and new drugs to treat cells. He stressed it’s important to spend most of the time focusing on formulating your problem than the model itself to optimize results. Scheu stressed the importance of security/privacy controls and integrity and how to balance research and development timelines. Cyber should be “embraced” to adapt more quickly and “good hygiene” is essential, however you don’t want to hinder the process while ensuring people have the right tools for privacy and data protection.

Krista Toler talked about the tremendous opportunities that AI presents and the current knowledge and skills gap that exists as well as tech capabilities and expertise. She highlighted how collaborations across sectors can advance the industry and healthcare as a whole. Engaging external partners to help in doing so safely & ethically is essential.

View Presentations:

Johnson

Toler

Mike Bolinder (BioCrossroads), Brad Keiser (Boston Scientific), Amy Brown (Authenticx), Milin Shah (Elevance Health) and Emily Webber (IU Health)

Over lunch, a panel on product development was moderated by Mike Bolinder, Senior VP and Chief Innovation Officer at BioCrossroads.  Panel members consisted of Amy Brown, founder & CEO of Authenticx; Brad Keiser, director of process development at Boston Scientific; Emily Webber, Chief Medical Information Officer at IU Health, and Milind Shah, head of strategy & solutions- Carelon Digital Platforms at Elevance Health.

Amy Brown illustrated how Authentic uses AI, machine learning, voice technology and software integrations to provide multiple methods for customers and business partners to communicate.  Brown illustrated how Authenticx uses AI, machine learning, voice technology and software integrations to provide multiple methods for customers and business partners to listen to the voices of their customers, and respond effectively.  Brown commented when a conversation is held through a telephonic or digital channel, ideas, language, words and nonverbal communication exchanged is “data”.  It is unstructured data – it doesn’t conform to a particular format that can be easily assessed.  This unstructured data is full of insights and intelligence that using technology can be structured and therefore mined for the insights it can bring us.  This realization is what sparked the idea for Authenticx.

Brad Keiser touched on how Boston Scientific uses AI to aid employees to transform lives through innovative medical solutions that improve the health of patients around the world.  Boston Scientific continually innovates products and technologies through organic Research & Development, strategic collaborations, and business development to treat complex cardiovascular, respiratory, digestive, oncological, neurological, and urological diseases and conditions.

Milind Shah provided insight from a payor’s perspective on overall Digital Transformation and tools to provide better experiences and support to customers, their associates, and providers by focusing on the fundamentals and embracing transformation. An example of this is their Sydney mobile app that allows members with personalized matches of a member to the right doctor for their care. They also enable providers to deliver care and reduce their administrative burden through streamlining provider data management and clinical data integration tools. They also equip their associates with insights from data and technology to assist members with a high level of service.

Emily Webber represented the provider perspective with IU Health treating over 38,000 patients across the state in addition to training clinical and support teams. Webber outlined the importance of using technology across the health system through internal and external communications as well as with individual patients. She shared that IU Health defines value in a way that helps them accept the risks of new or unproven technology. An example in the past is how IU Health used SMS tools for COVID testing sites, currently IU health uses data driven tools for clinical trials through the IU School of Medicine as well as partnering with Google to provide big data to their clinical teams.  IU Health has also used the Indiana Health Information Exchange data for social initiatives such as Operation Allies Welcome in partnership with Camp Atterbury. The panel summarizes well how data and technology can be used In so many ways touching all parts of the life sciences industry.

View Presentations:

Brown

Keiser

Jeff Kirk (Taft Law), Max Maile (Parkview Health), Paul Fletcher (Sanofi), and Matt Manley (Roche Diagnostics)

The closing panel for the day focused on patient care. The panel was moderated by Jeff Kirk, Partner at Taft Stettinius & Hollister LLP.  Panelists included Paul Fletcher, Head of Marketing & New Dermatology Indications at Sanofi; Matt Manley, VP of Digital Health Solutions at Roche Diagnostics; and Max Maile, Senior VP of Digital Health for Parkview Health.

Paul Fletcher held significant marketing leadership roles at companies including Eli Lilly & Company, Biogen, and most recently at Sanofi, where he led the launch of their blockbuster agent, DUPIXENT®. Fletcher talked about how in those experiences’ collaborations, building a “championship team”, leveraging Key Opinions Leaders and flexibility are important but the implementation of analytics to ensure a smooth launch to help treat patients is essential.

Max Maile partners with system leaders to ensure the growth and strategic direction of digital services across the Parkview Health system. These services include MyChart, the Parkview app, the Digital Care Center and additional digital health initiatives. Maile emphasized health systems are huge repository for data on genetics, pharma and diseases such as cancer. This data is collected through patient portals on labs, imaging, triage, notes, messaging, check-in, prescription refills and connected data as a part of the health system. Technology can expand to include remote patient monitoring, digital care centers and ambient listening devices. Maile shared that due to AI, healthcare is poised to be the most transformed industry by 2040.

Matt Manley shared how Roche is using its Navify platform for a more connected and agile way of using digital technology to provide better care to patients. An example of this is Roche Group’s R&D units (Roche, Genentech, Foundation Medicine and Flatiron) use of digital technology to treat over 16 million cancer patients globally. He shared how 70% of medical decisions are influenced by laboratory test results and generate massive amounts of data and information. This digital information can be used to not only innovate diagnostics but communicating data for proper treatment. Manley shared that unfortunately 97% of healthcare data is currently unused.  In summary, Manley commented how everyone in the industry shares common challenges such as staff shortages, increasing financial pressure, complexity of digital transformation, increasing expectations by patients and more. Therefore, it’s crucial to “smash down the silos” by “opening the ecosystem” to unlock new possibilities connecting data in the areas of diagnosis, treatment and home health to accelerate access to innovation and generate new insights.

View Presentation:

Maile

This was the final conference in the 2023-2024 Indiana Life Sciences Collaboration Conference Series. New topics for 2024-2025 will be introduced in the next couple of months. Topics, dates and locations will be posted on the Kelley Center for the Business of Life Sciences website.

*The Center for the Business of Life Sciences has presented the Indiana Life Sciences Collaboration Conference Series since 2006. The series brings together a remarkable array of academics and leaders in the life sciences industry, government, and economic development communities to focus on issues that impact the life sciences, business, and Hoosiers’ lives.

L to R: Sam Banks (IU Health), Peter Gallagher (Boston Scientific), Elizabeth Wilson (Eli Lilly) share their experience in supply chain in the life sciences industry at the 2024 IU Life Sciences Day at Kelley event.

The Center for Business of Life Sciences at Indiana University – Kelley School of Business hosted the 2024 edition of Annual Life Sciences Day on Friday, April 12^th. The topic for this year’s panel discussion was Supply Chain Resilience – From Suppliers to Finished Goods. Corporate representatives from Boston Scientific (Peter Gallagher), Eli Lilly (Elizabeth Wilson), and IU Health (Sam Banks) shared their experience, challenges, strategies, and best practices with CBLS students. A special thanks to the Workman Family Charitable Trust and the Voris Family Foundation for sponsoring this event!

Over the past decade, the industry has encountered a series of profound disruptions that have tested the resilience of its supply chain. Global events such as natural disasters, COVID-19 pandemic, geopolitical tensions between US and China, blockage of the Suez Canal, along with local regulatory changes within the US have underscored the need for adaptive strategies and agile responses to ensure continuity and reliability. The panel members brought a wealth of experience and insights on how to anticipate, adapt, and innovate in response to these disruptions. It was interesting to see different perspectives from a large pharma, a leading medical devices company, and a significant hospital network. Our panelists added further value from their prior experience from within and outside the industry.

The panelists shared with the group some crucial principles in supply chain management – process discipline, vendor management, strategic partnerships, resource allocation, value analysis and clinical effectiveness, and supply chain integration. One of the most surprising takeaways was how the life sciences industry mirrors the trends in the automotive industry with a lag of some decades. It was also interesting to find how significant relationship building and people management is to reduce cycle time and ensure business continuity. As a business graduate, it was a great learning experience to know how the function intersects with marketing and finance and impacts decisions on developing business intelligence.

CBLS Center Director, George Telthorst applauds students who earned their Certificate in the Business of Life Sciences.

At the conclusion of the panel, George Telthorst, Director of the Kelley Center for the Business of Life Sciences, recognized 36 undergraduate and graduate students this year from Kelley, O’Neill and the College of Arts & Sciences. The day wrapped up with a celebratory luncheon where students had an opportunity to network with the panel members.CBLS facilitates collaboration among students, faculty, life science enterprises, and corporate affiliates to address pertinent industry challenges and inquiries while fostering valuable networking avenues for students, faculty, businesses, and associates. The center aims to bolster Indiana’s life science sector through enhanced connectivity through events staggered throughout the academic year.

MBA Honorees

Junghwan An                                                    Lane Holmes                        Karan Sharma

Divianshu Bhardwaj                                        Kendall Law                           Deepti Singh

Tosin Bowale                                                     Grant Lewis                            Sanjay Sukumar

Ruan Dos Santos                                              Harry Lubis                             Ryan Thompson

Varis Duangamaneerattanachai                    Uchenna Ogbejesi                DJ Tuttle

Oluwaseun Fakorede                                       Claire Perkins                         Jimmy Wang

Liam Fitzgerald                                                 Alyssa Poticha

Masters of Sciences in Healthcare Management Honorees

Jonathan Dusleag                                              Nicholas Peirick                        Van Tran

Christian Gettelfinger                                       Adam Pratt                                  Aisha Yusuf

Graduate Science Honoree

Chelsea Simpson

Undergraduate Business & Science Honorees

Lena Babiker                                                     Haripriya Jalluri                         Christopher Parker

Rishma Chauhan                                              Alyson Kniola                              Isabella Schuhrke

Becca Feiler                                                       Noah Newcomb

The Certificate in the Business of Life Sciences certificate is for undergraduate students and graduate students, Kelley School of Business students and students from across the Bloomington campus who are passionate about a career in the life sciences and a desire for an understanding of how business and science interact to produce health-related outcomes. 

For undergraduate or graduate students, the benefits are many:

• unique opportunities to interact with leaders in the industry and with students and perspectives from many other disciplines
• coursework designed for deeper understanding of the business of life sciences companies
• involvement with multidisciplinary case studies and consulting projects

Learn More Here!

Pamela Udumba, Kelley MBA Class of 2024

Pamela Udumba – Ecolab Intern 2023 & Kelley MBA, Class of 2024

Interview by Deepti Singh, Kelley Life Sciences MBA Class of 2024

During the summer, I had the opportunity to intern at Ecolab, where I was part of the Healthcare Innovation program. Specifically, I worked as an MBA Marketing Intern within this function. I was introduced to this role and company through my participation in the National Black Conference.

Throughout my internship, I was primarily involved in the Healthcare Program Innovation to seek novel ways to accelerate Ecolab’s position in operating rooms.

One of the most significant challenges I faced was navigating the complex landscape of healthcare regulations within the United States and gaining a deep understanding of what truly matters to hospital stakeholders. This experience taught me that in the healthcare industry, personal connections and relationships are often more valuable than information you can find on the internet.

I had a fantastic experience when it came to networking with colleagues within the company. I was able to connect with professionals from various divisions, and I found that everyone was open and willing to engage in conversations with me.

This internship experience had a significant impact on my career goals. It helped me clarify and refine my professional aspirations. Additionally, I identified the need to further develop my analytical skills as I return for the second year of my MBA program.

During this summer internship, feel free to embrace failure as a learning opportunity. Don’t hesitate to adapt to new circumstances and environments. Ultimately, you’ll discover whether this path aligns with your aspirations. In any case, it’s a valuable and enriching experience.